Alpha Cells Secrete Glucagon: 7 Key Product Composition Insights
Abstract: Alpha cells secrete glucagon, a 29-amino-acid peptide critical for glucose homeostasis. This analysis reviews 7 key product composition insights, comparing leading brands (e.g., Novo Nordisk, Eli Lilly) on purity (>98% HPLC), stability, and bioactivity. Market trends project a 7.2% CAGR (2024–2030) driven by diabetes and obesity therapeutics. Technical trade-offs include synthetic vs. recombinant production: synthetic offers high purity but lower yield; recombinant ensures scalability but risks immunogenicity. Product certifications (GMP, ISO 13485) and factory audits (FDA, EMA) are essential for quality assurance. Selection criteria prioritize peptide sequence fidelity, endotoxin levels (<1 EU/mg), and cold-chain logistics (2–8°C). Industry data from 1,200+ clinical trials underscore glucagon’s expanding role in hypoglycemia rescue and metabolic disorders.